{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-05-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "submissions": [ { "submission_type": "SUPPL", "submission_number": "14", "submission_status": "AP", "submission_status_date": "20210310", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "66735", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125521s014lbl.pdf", "date": "20210311", "type": "Label" }, { "id": "66737", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125521Orig1s014ltr.pdf", "date": "20210311", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "2", "submission_status": "AP", "submission_status_date": "20180419", "review_priority": "STANDARD", "submission_class_code": "UNKNOWN", "application_docs": [ { "id": "53783", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/125521Orig1s002ltr.pdf", "date": "20180423", "type": "Letter" }, { "id": "53792", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125521Orig1s002lbl.pdf", "date": "20180423", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "20", "submission_status": "AP", "submission_status_date": "20200326", "review_priority": "PRIORITY", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "62351", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125521Orig1s020ltr.pdf", "date": "20200327", "type": "Letter" }, { "id": "62352", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125521s020lbl.pdf", "date": "20200327", "type": "Label" }, { "id": "63084", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/125521S20 ixekizumab unireview prea.pdf", "date": "19000101", "type": "Pediatric Other" } ] }, { "submission_type": "SUPPL", "submission_number": "9", "submission_status": "AP", "submission_status_date": "20180517", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "54259", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125521s009lbl.pdf", "date": "20180521", "type": "Label" }, { "id": "54266", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/125521Orig1s009ltr.pdf", "date": "20180521", "type": "Letter" } ] }, { "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160322", "review_priority": "STANDARD", "submission_class_code": "TYPE 1", "submission_class_code_description": "Type 1 - New Molecular Entity", "application_docs": [ { "id": "39986", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125521s000lbl.pdf", "date": "20160323", "type": "Label" }, { "id": "43336", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/125521Orig1s000TOC.html", "date": "20160503", "type": "Review" }, { "id": "9776", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/125521Orig1s000ltr.pdf", "date": "20160324", "type": "Letter" }, { "id": "24378", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/125521Orig1s000SumR.pdf", "date": "20160503", "type": "Summary Review" } ] }, { "submission_type": "SUPPL", "submission_number": "19", "submission_status": "AP", "submission_status_date": "20200529", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "63381", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125521Orig1s019ltr.pdf", "date": "20200602", "type": "Letter" }, { "id": "63391", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125521s019lbl.pdf", "date": "20200602", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "31", "submission_status": "TA", "submission_status_date": "20231120", "review_priority": "N/A", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "77759", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/125521Orig1s031ltr.pdf", "date": "20240308", "type": "Letter" }, { "id": "77777", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125521Orig1s031lbl.pdf", "date": "20240311", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "23", "submission_status": "AP", "submission_status_date": "20220504", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy" }, { "submission_type": "SUPPL", "submission_number": "3", "submission_status": "AP", "submission_status_date": "20170705", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "48915", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125521s003lbl.pdf", "date": "20170705", "type": "Label" }, { "id": "48921", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/125521Orig1s003ltr.pdf", "date": "20170706", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "11", "submission_status": "AP", "submission_status_date": "20180316", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "53058", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/125521Orig1s011ltr.pdf", "date": "20180320", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "28", "submission_status": "AP", "submission_status_date": "20230913", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "75450", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/125521Orig1s028ltr.pdf", "date": "20230914", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "32", "submission_status": "AP", "submission_status_date": "20240820", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "79454", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/125521Orig1s032ltr.pdf", "date": "20240821", "type": "Letter" }, { "id": "79461", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125521s032lbl.pdf", "date": "20240822", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "24", "submission_status": "AP", "submission_status_date": "20220727", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "71652", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/125521Orig1s024ltr.pdf", "date": "20220728", "type": "Letter" }, { "id": "71656", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125521s024lbl.pdf", "date": "20220728", "type": "Label" }, { "id": "71657", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125521s024lbl.pdf#page=21", "date": "20220728", "type": "Medication Guide" } ] }, { "submission_type": "SUPPL", "submission_number": "16", "submission_status": "AP", "submission_status_date": "20190823", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "59846", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/125521Orig1s016ltr.pdf", "date": "20190827", "type": "Letter" }, { "id": "59904", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125521s016lbl.pdf", "date": "20190904", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "4", "submission_status": "AP", "submission_status_date": "20171201", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "50580", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/125521Orig1s004ltr.pdf", "date": "20171201", "type": "Letter" }, { "id": "50593", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125521s004lbl.pdf", "date": "20171204", "type": "Label" } ] } ], "application_number": "BLA125521", "sponsor_name": "ELI LILLY AND CO", "openfda": { "application_number": [ "BLA125521" ], "brand_name": [ "TALTZ" ], "generic_name": [ "IXEKIZUMAB" ], "manufacturer_name": [ "Eli Lilly and Company" ], "product_ndc": [ "0002-7724", "0002-1445", "0002-8900", "0002-8905" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "substance_name": [ "IXEKIZUMAB" ], "rxcui": [ "1745103", "1745108", "1745112", "1745114", "2674931", "2674932", "2674933", "2674934" ], "spl_id": [ "246fceb3-0f60-4bd7-8f06-4f34537f5d95" ], "spl_set_id": [ "ac96658a-d7dc-4c7c-8928-2adcdf4318b2" ], "package_ndc": [ "0002-1445-01", "0002-1445-11", "0002-1445-27", "0002-1445-09", "0002-1445-61", "0002-7724-01", "0002-7724-11", "0002-7724-99", "0002-8900-01", "0002-8900-11", "0002-8905-01", "0002-8905-11" ], "nui": [ "N0000191495", "N0000191494" ], "pharm_class_epc": [ "Interleukin-17A Antagonist [EPC]" ], "pharm_class_moa": [ "Interleukin-17A Antagonists [MoA]" ], "unii": [ "BTY153760O" ] }, "products": [ { "product_number": "001", "reference_drug": "No", "brand_name": "TALTZ", "active_ingredients": [ { "name": "IXEKIZUMAB", "strength": "80MG/ML" } ], "dosage_form": "INJECTABLE", "route": "INJECTION", "marketing_status": "Prescription" } ] } ] }